The 10-year survival beginning five years after diagnosis IS seen as about 10 percent lower than in age-matched general population, a gap that persists for many years, The study reports. People who were treated...
Pediatric patients whose cancer had relapsed were successfully matched to new gene-targeted therapies in large European trial, according to a study in the AACR journal Cancer Discovery.
Editor’s note: This story, written by Anna Azvolinsky, first appeared in Leading Discoveries, a magazine and website that raises awareness of the AACR and its members. To learn more about Dr. Carpten’s involvement with AACR...
Compared to urbanites, rural residents tend to think little can be done about cancer and feel overloaded with cancer-related information.
A study finds that people aged 20-30 years in the U.S. had the biggest increase in metastatic, early-onset colorectal cancer between 2000 and 2016, and that Blacks and Hispanics may have the highest risk.
New interventions and therapies lead to a near doubling of survival of patients with acute lymphoblastic leukemia following relapse after transplants.
The first classification of childhood tumors separating them from adult cancers will be published as a "blue book" by the World Health Organization.
Study: Short-term, severe calorie restriction can reduce sugar and other substances in blood that may feed cancer cells and boost the antitumor immune response. A diet involving short-term, severe calorie restriction was safe and...
“Patient-centered” study seeks to assess quality of time that patients live by measuring the “treatment-free survival” outcome. A treatment combining two immunotherapies gave patients with advanced kidney cancer a longer time without subsequent treatment...
Aggressive treatments given to younger patients with B-cell non-Hodgkin lymphoma may leave them vulnerable to other diseases later in life, according to a study in the AACR journal Cancer Epidemiology, Biomarkers & Prevention.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now